| Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer |
Biospecimen Collection, Retinoid 9cUAB30, Therapeutic Conventional Surgery |
Active, not recruiting |
| STEMVAC in Patients With Early Stage Triple Negative Breast Cancer |
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine, Sargramostim |
Recruiting |
| Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast |
Afimoxifene, Laboratory Biomarker Analysis, Placebo, Tamoxifen Citrate |
Recruiting |
| Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia |
Imiquimod, Topical Fluorouracil |
Active, not recruiting |
| Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission |
Laboratory Biomarker Analysis, pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine, Sargramostim |
Active, not recruiting |